
Cancer Research UK has appointed Professor Sir Bruce Ponder as a trustee. Ponder is emeritus professor of oncology at Cambridge …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

